Medlive Technology Co Ltd
Medlive Technology's GHG Emissions Data Preview
In 2023, Medlive Technology completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
However, Medlive Technology has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Medlive Technology's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Medlive Technology amounted to 60,102 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Medlive Technology decreased by 11.3%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Medlive Technology's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Medlive Technology's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Medlive Technology were 0 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
What are Medlive Technology's Scope 2 emissions?
In 2023, Medlive Technology reported Scope 2 greenhouse gas (GHG) emissions of 60,102 tCOâ‚‚e without specifying the calculation method.
Has Medlive Technology reduced its Scope 2 emissions over time?
Since 2021, Medlive Technology's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 10.82%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Medlive Technology's Scope 2 emissions (Unspecified Calculation Method) fell by 11.3% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
What methodology does Medlive Technology use for Scope 2 reporting?
In 2023, Medlive Technology reported its Scope 2 emissions using an unspecified methodology.
Medlive Technology's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Medlive Technology's Value Chain Emissions
In 2023, Medlive Technology reported 768,176 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2023 disclosure of Medlive Technology includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year.
Medlive Technology's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Medlive Technology's Scope 3 emissions?
In 2023, Medlive Technology reported total Scope 3 emissions of 768,176 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Insights into Medlive Technology's Total Carbon Footprint
In 2023, Medlive Technology reported a total carbon footprint of 828,278 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 1,122.41% increase compared to 2022, suggesting a rise in emissions across its operations or value chain.
The largest contributor to Medlive Technology's total carbon footprint was Scope 3 emissions, accounting for 92.74% of the company's total carbon footprint, followed by Scope 2 emissions at 7.26%.